[3] Parish H.A., Gilliom R.D., Purcell W.P., Browne R.K., Spirk R.F., White H.D.,
Syntheses and Diuretic Activity of 1,2-dihydro-2-(3-pyridyl)-3H-pyrido[2,3-d]pyrimidin-4-one and Related Compounds,
J. Med. Chem., 25: 98-102 (1982).
[6] Na Y.H., Hong S.H., Lee J.H., Park W.K., Baek D.J., Koh H.Y., Cho Y.S., Choo H., Pae A.N.,
Novel Quinazolinone Derivatives as 5-HT7 Receptor Ligands,
Bioorg. Med. Chem., 16: 2570-2578 (2008).
[8] Hour M.J., Huang L.J., Kuo S.C., Xia Y., Bastow K., Nakanishi Y., Hamel E., Lee K.H.,
6-Alkylamino- and 2,3-Dihydro-3′-methoxy-2-phenyl-4-quinazolinones and Related Compounds: Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization,
J. Med. Chem.,
43: 4479-4487 (2000).
[19] Chen J., Wu D., He F., Liu M., Wu H., Ding J., Su W.,
Gallium(III) Triflate-Catalyzed One-Pot Selective Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones and Quinazolin-4(3H)-ones,
Tetrahedron Lett.,
49: 3814–3818 (2008).
[21] Chinigo G.M., Paige M., Grindrod S., Hamel E., Dakshanamurthy S., Chruszcz M., Minor W., Milton L., Brown M.L.,
Asymmetric Synthesis of 2,3-Dihydro-2-Arylquinazolin-4-ones: Methodology and Application to a Potent Fluorescent Tubulin Inhibitor with Anticancer Activity,
J. Med. Chem.,
51: 4620-4631 (2008).